Veterinary Biologics Market by Player, Region, Type, Application and Sales Channel 2024-2030
The global Veterinary Biologics market size is estimated to be $12.1 billion in 2023, and will reach $22.2 billion by 2032, growing at a CAGR of 7% during the forecast period from 2024 to 2032.
This report studies the Veterinary Biologics market, covering market size for segment by type (Attenuated Live Vaccines, Inactivated Vaccines, etc.), by application (Companion Animals, Poultry, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Zoetis, Ceva Sant? Animale, Bayer, Boehringer Ingelheim, Merck, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Veterinary Biologics from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Veterinary Biologics market.
Leading Players of Veterinary Biologics including:
Zoetis
Ceva Sant? Animale
Bayer
Boehringer Ingelheim
Merck
Elanco Animal Health
Sanofi-Aventis
Vetoquinol
Novartis
Heska
Virbac
Dechra Pharmaceuticals
IDEXX Laboratories
Phibro Animal Health
Hester Biosciences
Market split by Type:
Attenuated Live Vaccines
Inactivated Vaccines
DNA Vaccines
Recombinant Vaccines
Others
Market split by Application:
Companion Animals
Poultry
Swine
Cattle
Sheep & Goats
Market split by Sales Channel:
Direct Channel
Distribution Channel
Market split by Region/Country:
North America (United States and Canada)
Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
South America (Brazil, Mexico, and Argentina, etc.)
Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
